Published in Lahey Clin Found Bull on April 08, 1968
Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. J Clin Invest (1966) 2.43
IMMUNOREACTIONS INVOLVING PLATELETS. V. POST-TRANSFUSION PURPURA DUE TO A COMPLEMENT-FIXING ANTIBODY AGAINST A GENETICALLY CONTROLLED PLATELET ANTIGEN. A PROPOSED MECHANISM FOR THROMBOCYTOPENIA AND ITS RELEVANCE IN "AUTOIMMUNITY". J Clin Invest (1961) 2.28
Preservation of vascular integrity in organs perfused in vitro with a platelet-rich medium. Nature (1969) 2.16
The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest (1989) 1.94
T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates. N Engl J Med (1983) 1.91
A platelet and granulocyte membrane defect in paroxysmal nocturnal hemoglobinuria: usefulness for the detection of platelet antibodies. J Clin Invest (1969) 1.91
Use of "compatible" platelet transfusions in treatment of congenital isoimmune thrombocytopenic purpura. N Engl J Med (1969) 1.71
Enzymatic amplification of platelet-specific messenger RNA using the polymerase chain reaction. J Clin Invest (1988) 1.63
Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin:platelet factor 4 complexes. J Lab Clin Med (1996) 1.58
A study of variables affecting the quality of platelets stored at "room temperature". Transfusion (1976) 1.52
TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: a report of 2 fatalities. Transfusion (2003) 1.50
Antibodies in sulfonamide-induced immune thrombocytopenia recognize calcium-dependent epitopes on the glycoprotein IIb/IIIa complex. Blood (1994) 1.40
Heparin-induced thrombocytopenia: understanding improves but questions remain. J Lab Clin Med (1996) 1.39
A study of criteria for blood donor deferral. Transfusion (1980) 1.39
Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest (1994) 1.38
Rapid determination of platelet alloantigen genotypes by polymerase chain reaction using allele-specific primers. Transfusion (1994) 1.33
Effect of anticoagulant and ABO incompatibility on recovery of transfused human platelets. Blood (1965) 1.28
Coincident classic hemophilia and "idiopathic" thrombocytopenic purpura in patients under treatment with concentrates of antihemophilic factor (factor VIII). N Engl J Med (1983) 1.27
Sites of platelet destruction in idiopathic thrombocytopenic purpura. Br J Haematol (1969) 1.24
Isolation and immunologic characterization of the human platelet alloantigen, P1A1. Mol Immunol (1979) 1.21
Heparin-induced thrombocytopenia and thrombosis. Am J Hematol (2006) 1.20
Post-transfusion purpura: successful treatment by exchange transfusion. N Engl J Med (1972) 1.18
Increased splenic pooling and the pathogenesis of hypersplenism. Am J Med Sci (1967) 1.18
Blood group A and B antigens are strongly expressed on platelets of some individuals. Blood (2000) 1.17
Detection of drug-dependent antibodies by the 51Cr platelet lysis test: documentation of immune thrombocytopenia induced by diphenylhydantoin, diazepam, and sulfisoxazole. Am J Hematol (1977) 1.16
Detection of drug-dependent, platelet-reactive antibodies by antigen-capture ELISA and flow cytometry. Transfusion (1990) 1.14
Absence of the platelet receptor for drug-dependent antibodies in the Bernard-Soulier syndrome. J Clin Invest (1978) 1.14
Expression of HLA-B12, HLA-B8, w4, and w5 on platetelets. Transplant Proc (1977) 1.10
Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosis. J Lab Clin Med (2001) 1.10
The sites of hemoglobin catabolism. Blood (1965) 1.08
Febrile transfusion reaction: what blood component should be given next? Vox Sang (1982) 1.08
Studies of platelet concentrates stored at 22 C nad 4 C. Transfusion (1973) 1.07
Incidence of the Nak(a)-negative platelet phenotype in African Americans is similar to that of Asians. Transfusion (1996) 1.07
Development of an automated blood inventory and information system for a regional transfusion service. Transfusion (1970) 1.07
Fab-mediated binding of drug-dependent antibodies to platelets in quinidine- and quinine-induced thrombocytopenia. J Clin Invest (1985) 1.06
Drug-antibody-platelet interaction in quinine- and quinidine-induced thrombocytopenia. J Clin Invest (1982) 1.05
Deletion of the platelet-specific alloantigen PlA1 from platelets in Glanzmann's thrombasthenia. J Clin Invest (1978) 1.05
Polymorphism of human platelet membrane glycoprotein IIb associated with the Baka/Bakb alloantigen system. Blood (1990) 1.05
On the association of the platelet-specific alloantigen, Pena, with glycoprotein IIIa. Evidence for heterogeneity of glycoprotein IIIa. J Clin Invest (1987) 1.02
Platelet migration inhibition: a new method for detection of platelet antibodies. Blood (1975) 1.01
Characteristics of quinine- and quinidine-induced antibodies specific for platelet glycoproteins IIb and IIIa. Blood (1991) 1.00
Quinine-induced immune thrombocytopenia associated with hemolytic uremic syndrome: a new clinical entity. Blood (1991) 1.00
Further studies of the human platelet receptor for quinine- and quinine-dependent antibodies. J Immunol (1981) 1.00
Complexes of heparin and platelet factor 4 specifically stimulate T cells from patients with heparin-induced thrombocytopenia/thrombosis. Blood (1999) 0.99
Clinical significance of platelet-specific antigens and antibodies. Prog Clin Biol Res (1984) 0.98
Response of human platelets to activating monoclonal antibodies: importance of Fc gamma RII (CD32) phenotype and level of expression. Blood (1992) 0.98
Neonatal alloimmune thrombocytopenic purpura and congenital porencephaly in two siblings associated with a "new" maternal antiplatelet antibody. Blood (1985) 0.97
Uncommon abnormalities of blood associated with chronic ulcerative colitis. Med Clin North Am (1966) 0.95
Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug. J Thromb Haemost (2004) 0.95
Characterization of the humoral immune response in heparin-induced thrombocytopenia. Am J Hematol (1997) 0.95
Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis. J Thromb Haemost (2011) 0.94
Inhibition of platelet adhesion to collagen by monoclonal anti-CD36 antibodies. Br J Haematol (1996) 0.94
Quinine-induced immune thrombocytopenia with hemolytic uremic syndrome: clinical and serological findings in nine patients and review of literature. Am J Hematol (1994) 0.94
Severe neonatal alloimmune thrombocytopenia caused by antibodies to human platelet antigen 3a (Baka) detectable only in whole platelet assays. Transfusion (2003) 0.93
Relative hemostatic effectiveness of human platelets stored at 4 degrees and 22 degrees C. J Lab Clin Med (1978) 0.92
Changes associated with platelet aging. Thromb Diath Haemorrh (1972) 0.92
Treatment of thrombotic thrombocytopenic purpura by exchange transfusion. Am J Hematol (1977) 0.92
Determination of neutrophil antigen gene frequencies in five ethnic groups by polymerase chain reaction with sequence-specific primers. Transfusion (1996) 0.92
Heparin-induced thrombocytopenia and thrombosis. N Engl J Med (1995) 0.92
Successful transfusion of platelets "mismatched" for HLA antigens to alloimmunized thrombocytopenic patients. Am J Hematol (1977) 0.92
Prenatal diagnosis of neonatal alloimmune thrombocytopenia using allele-specific oligonucleotide probes. Blood (1991) 0.91
Platelet kinetics in patients with idiopathic thrombocytopenic purpura and moderate thrombocytopenia. Blood (1985) 0.91
Structural features of the quinidine and quinine molecules necessary for binding of drug-induced antibodies to human platelets. J Lab Clin Med (1984) 0.90
Direct quantitation of platelet-associated IgG by electroimmunoassay. Blood (1982) 0.90
Concurrence of anaphylaxis and acute heparin-induced thrombocytopenia in a patient with heparin-induced antibodies. J Vasc Surg (1998) 0.89
The P1A alloantigen system is a sensitive indicator of the structural integrity of the amino-terminal domain of the human integrin beta 3 subunit. Blood Cells Mol Dis (1995) 0.89
Lipid composition of freshly prepared and stored platelet concentrates. Blood (1980) 0.88
Effects of pH treatments and deglycosylation of rabbit immunoglobulin G on the binding of C1q. J Biol Chem (1980) 0.88
Studies of the fate of platelets in rats and man. Blood (1969) 0.87
Post-transfusion purpura: immunologic aspects and therapy. N Engl J Med (1974) 0.87
An antibody from a patient with ranitidine-induced thrombocytopenia recognizes a site on glycoprotein IX that is a favored target for drug-induced antibodies. Blood (1998) 0.87
Thrombotic thrombocytopenic purpura: early and late responders. Am J Hematol (1997) 0.86
Post-transfusion purpura: an enigma of alloimmunization. Am J Hematol (1980) 0.86
An amino acid polymorphism within the RGD binding domain of platelet membrane glycoprotein IIIa is responsible for the formation of the Pena/Penb alloantigen system. J Clin Invest (1992) 0.86
Antibodies from patients with heparin-induced thrombocytopenia/thrombosis recognize different epitopes on heparin: platelet factor 4. Blood (1998) 0.85
Identification of Bakb, a new platelet-specific antigen associated with posttransfusion purpura. Blood (1988) 0.85
"Gestational" thrombocytopenia: a plea for conservative management. N Engl J Med (1990) 0.85
Platelet sequestration studies in man. Br J Haematol (1972) 0.84
Platelet satellitism and phagocytosis by neutrophils: association with antiplatelet antibodies and lymphoma. Am J Hematol (1978) 0.84
Where have all the platelets gone?--A strategy for monitoring platelet usage. Wis Med J (1982) 0.84
Studies of the mechanism of "hypersplenic" thrombocytopenia in rats. J Lab Clin Med (1967) 0.84
Importance of white blood cells in platelet storage. Vox Sang (1984) 0.84
Effect of HLA Bw4/Bw6 compatibility on platelet transfusion responses of refractory thrombocytopenic patients. Blood (1982) 0.83
A comparison of factor VIII activity in cryoprecipitates prepared from ACD and CPD plasma. Transfusion (1972) 0.82
Posttransfusion purpura: therapeutic failure of PlAl-negative platelet transfusion. Am J Hematol (1979) 0.82
Quinine- and quinidine platelet antibodies can react with GPIIb/IIIa. Br J Haematol (1987) 0.82
Sensitivity to a metabolite of diclofenac as a cause of acute immune hemolytic anemia. Blood (1997) 0.82
Prepooled cryoprecipitate for treatment of hemophilia A. Transfusion (1983) 0.81
Histocompatibility antigens of human plasma. Localization to the HLD-3 lipoprotein fraction. Transplantation (1973) 0.81
Posttransfusion purpura associated with alloantibody specific for the platelet antigen, Pen(a). Am J Hematol (1988) 0.81
Identification of glycoprotein Ib as a target for autoantibody in idiopathic (autoimmune) thrombocytopenic purpura. Blood (1986) 0.81
Quantitative determination of platelet surface alloantigens using a monoclonal probe. Hum Immunol (1986) 0.81
Procurement and identification of HL-A lymphocytotoxic antibodies in sera of nonpregnant, multiparous blood donors. Transfusion (2003) 0.81
Paid time off for blood donation--an incentive to be less than truthful? Transfusion (1997) 0.81
Immune hemolytic anemia caused by sensitivity to a metabolite of etodolac, a nonsteroidal anti-inflammatory drug. Transfusion (2000) 0.80
Neutrophil antigen (FcgammaRIIIB) SH gene frequencies in six racial groups. Blood (1999) 0.80
TTP: new clues to the etiology of an enigmatic disease. N Engl J Med (1977) 0.80